Michael Sarcone
Stock Analyst at Jefferies
(0.16)
# 3,685
Out of 4,667 analysts
5
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $94.51 | +0.52% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $143.72 | -13.03% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $7.64 | +30.89% | 1 | Mar 21, 2023 | |
| AXGN Axogen | Assumes: Buy | $15 | $13.06 | +14.89% | 1 | Nov 11, 2022 | |
| EDAP EDAP TMS | Initiates: Buy | $11 | $2.59 | +325.53% | 1 | Nov 1, 2022 |
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $94.51
Upside: +0.52%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $143.72
Upside: -13.03%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $7.64
Upside: +30.89%
Axogen
Nov 11, 2022
Assumes: Buy
Price Target: $15
Current: $13.06
Upside: +14.89%
EDAP TMS
Nov 1, 2022
Initiates: Buy
Price Target: $11
Current: $2.59
Upside: +325.53%